Literature DB >> 25733161

X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor.

V Alterio1, M Tanc, J Ivanova, R Zalubovskis, I Vozny, S M Monti, A Di Fiore, G De Simone, C T Supuran.   

Abstract

6-Sulfamoyl-saccharin was investigated as an inhibitor of 11 α-carbonic anhydrase (CA, EC 4.2.1.1) isoforms of human (h) origin, hCA I-XIV, and X-ray crystallographic data were obtained for its adduct with hCA II, the physiologically dominant isoform. This compound possesses two potential zinc-binding groups, the primary sulfamoyl one and the secondary, acylatedsulfonamide. Saccharin itself binds to the Zn(II) ion from the CA active site coordinating with this last group, in deprotonated (SO2N(-)CO) form. Here we explain why 6-sulfamoyl-saccharin, unlike saccharin, binds to the metal ion from the hCA II active site by its primary sulfonamide moiety and not the secondary one as saccharin itself. Our study is useful for shedding new light to the structure-based drug design of isoform-selective CA inhibitors of the sulfonamide type.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25733161     DOI: 10.1039/c4ob02648a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  5 in total

1.  Computational Prediction of the Binding Pose of Metal-Binding Pharmacophores.

Authors:  Johannes Karges; Ryjul W Stokes; Seth M Cohen
Journal:  ACS Med Chem Lett       Date:  2022-02-24       Impact factor: 4.345

2.  4-(3-Alkyl/benzyl-guanidino)benzenesulfonamides as selective carbonic anhydrase VII inhibitors.

Authors:  Morteza Abdoli; Simone Giovannuzzi; Claudiu T Supuran; Raivis Žalubovskis
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 3.  Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site.

Authors:  Srishti Singh; Carrie L Lomelino; Mam Y Mboge; Susan C Frost; Robert McKenna
Journal:  Molecules       Date:  2018-04-30       Impact factor: 4.411

4.  The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors.

Authors:  Aleksandrs Pustenko; Alessio Nocentini; Paola Gratteri; Alessandro Bonardi; Igor Vozny; Raivis Žalubovskis; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

5.  Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluation.

Authors:  Paolo Guglielmi; Giulia Rotondi; Daniela Secci; Andrea Angeli; Paola Chimenti; Alessio Nocentini; Alessandro Bonardi; Paola Gratteri; Simone Carradori; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.